Assistance Publique des Hôpitaux de Paris SA

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Established: 1849-01-01

Employees: 10K

Market Cap: -

Website: http://www.aphp.fr

Clinical Trials

MEOPA to Improve Physical Therapy Results After Multilevel Surgery

Phase 3

Completed

Conditions: Cerebral Palsy
Quadriplegia
Spastic Diplegia
Hemiplegia

Interventions: Drug: MEOPA
Drug: Medicinal air

First Posted Date: 2008-03-10

Last Posted Date: 2023-02-03

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 64

Registration Number: NCT00632528

Locations: 🇫🇷
Robert Debré University Hospital, Paris, France

Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT

Phase 2

Completed

Conditions: Obstructive Airway Disease

Interventions: Drug: Formoterol/Budesonide
Drug: lactose

First Posted Date: 2008-02-27

Last Posted Date: 2013-05-06

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 32

Registration Number: NCT00624754

Locations: 🇫🇷
Hôpital Saint Louis, Paris, France

Impact of PET Scan on the Curative Strategy of Colo-rectal Cancers : A Randomized Study

Not Applicable

Completed

Conditions: Colorectal Cancer

Interventions: Other: semi-annual systematic PET-TDM
Other: PET-TDM for current indication

First Posted Date: 2008-02-27

Last Posted Date: 2016-03-18

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 240

Registration Number: NCT00624260

Locations: 🇫🇷
CHU Henri Mondor, Creteil, France

PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates

Phase 3

Completed

Conditions: Bronchopulmonary Dysplasia

Interventions: Drug: hydrocortisone
Drug: placebo

First Posted Date: 2008-02-26

Last Posted Date: 2018-10-02

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 523

Registration Number: NCT00623740

Locations: 🇫🇷
Hopital Robert Debre, Paris, France

Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus

Phase 2

Completed

Conditions: Lupus Erythematosus, Systemic

Interventions: Biological: Placebo, Pneumo23®
Biological: Prevenar® and Pneumo23®

First Posted Date: 2008-02-11

Last Posted Date: 2016-07-06

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 47

Registration Number: NCT00611663

Locations: 🇫🇷
CIC Vaccinologie - Hopital Cochin, Paris, France

Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus

Phase 2

Completed

Conditions: Diabetes Mellitus

Interventions: Drug: glibenclamide

First Posted Date: 2008-02-07

Last Posted Date: 2012-11-19

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 19

Registration Number: NCT00610038

Locations: 🇫🇷
Necker Hospital - Endocrinology Gynecology Pediatric unit, Paris, France

Effectiveness of a 24 Hour Phone Line on the Rate of Suicide Attempts in Borderline Patients

Not Applicable

Completed

Conditions: Borderline Personality Disorder

Interventions: Other: treatment as usual
Other: 24 hour phone line

First Posted Date: 2008-01-29

Last Posted Date: 2016-02-25

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 318

Registration Number: NCT00603421

Locations: 🇫🇷
Hôpital St Anne, Paris, France
🇫🇷
Hopital Cochin Centre de recherche Clinique Paris Centre, Paris, France

Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid

Phase 4

Completed

Conditions: Oral Anticoagulation
Deep Venous Thrombosis
Atrial Fibrillation
Pulmonary Embolism

First Posted Date: 2008-01-29

Last Posted Date: 2010-07-12

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 13

Registration Number: NCT00603317

Locations: 🇫🇷
Hopital Lariboisière - Service de médecine interne, Paris, France

Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients With Hand Osteoarthritis

Phase 3

Completed

Conditions: Hand Osteoarthritis

Interventions: Other: Adalimumab (Humira®)
Other: Placebo

First Posted Date: 2008-01-18

Last Posted Date: 2012-07-26

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 84

Registration Number: NCT00597623

Locations: 🇫🇷
CHU Henri Mondor, Créteil, France

Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH)

Phase 4

Terminated

Conditions: Small for Gestational Age

Interventions: Drug: rhGH (Norditropine SimpleXx®)
Drug: rhGH norditropine simple Xx

First Posted Date: 2008-01-18

Last Posted Date: 2015-04-21

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 10

Registration Number: NCT00597480

Locations: 🇫🇷
Hopital Saint Vincent de Paul, Paris, France

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy